Live News Categoriesequity

Harvard Bioscience, Inc. (HBIO) News

Track canonical SquawkNews coverage tagged to HBIO, Harvard Bioscience, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol HBIO Asset equity Sector Markets 90 days 1 Last 6.59 Updated Aug 11, 2026, 11:05 AM UTC Open live news feed

L Harvard Bioscience Sees FY2026 Sales $89.147M-$90.877M vs $88.600M Est. Harvard Bioscience (NASDAQ: HBIO ) sees FY2026 sales of $89.147 million-$90.877 million vs $88.600 million analyst estimate. Raises Full Year 2026 Revenue Guidance to 3%-5% Year Over Year Growth. EARNINGS | Aug 11, 2026, 11:05 AM UTC